Department of Experimental Immunotherapy - Zakład Immunoterapii Eksperymentalnej

Department of Experimental Immunotherapy

We are conducting intensive research to:

develop selective parasite-derived biological agents to propose the treatment of allergic, autoimmune, neurodegenerative and oncological diseases. Our research uses a “learning from parasites” approach using in vitro, ex vivo systems and in vivo animal models
identify infectious agents and immune response mechanisms involved in the pathogenesis of neurodegenerative diseases
identify and verify clinically valuable biomarkers of neurodegenerative diseases to qualify patients and predict their response to therapy
evaluate the antiparasitic properties of compounds and substances of natural origin against various developmental forms of intestinal nematodes

Potential of Th cell profiling in personalized multiple sclerosis treatment planning

OPUS 24, UMO-2022/47/B/NZ7/02729, 2023-2027, project leader: dr hab. n. med. i n. o zdr. Katarzyna Donskow-Łysoniewska, prof. UŁa.

Parylation as a factor regulating the expression of genes involved in immune processes.

MEiN,
Project leader:
dr hab. n. biol. Paweł Majewski
UŁa Project partner

News